Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optive in Patients Previously Using Systane for Dry Eye
NCT00399230Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of carboxymethylcellulose sodium + glycerin in dry eye disease (DED), sponsored by Janssen Pharmaceutical. Status: completed.
02
Drugs
carboxymethylcellulose sodium + glycerin
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT00399230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00399230.